SubjectWell is the risk-free clinical trials marketplace for patient recruitment
SubjectWell has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in October 2022.
SubjectWell's investors include Asset Management Ventures (AMV), Frontier Venture Capital, Geekdom Fund, Bertelsmann Investments, Windham Venture Partners.
SubjectWell is headquartered in Austin, United States.
SubjectWell is the risk-free clinical trials marketplace for patient recruitment
SubjectWell is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SubjectWell — Funding & Investors." VCBacked, October 18, 2022, https://www.vcbacked.co/company/subjectwell. Accessed August 14, 2026.
VCBacked. (2022). SubjectWell — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/subjectwell
{{cite web |title=SubjectWell — Funding & Investors |url=https://www.vcbacked.co/company/subjectwell |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated